Agnieszka 'Aj' J.
About Agnieszka 'Aj' J.
Agnieszka 'Aj' J. serves as the Vice President of Clinical Development at BridgeBio, bringing extensive experience in medical consulting and clinical research across various pharmaceutical companies. She has a strong background in genetics and rare diseases, along with a proven track record in project management and effective communication in clinical settings.
Current Role at BridgeBio
Agnieszka J. serves as Vice President of Clinical Development at BridgeBio, a position she has held since 2020. In this role, she directs and oversees clinical studies, including orphan drug registries. Her responsibilities involve strategic planning and project management, ensuring that clinical initiatives align with the company's objectives. Agnieszka's expertise in clinical development is complemented by her strong background in genetics and pediatrics, which informs her approach to managing clinical programs.
Education and Expertise
Agnieszka J. has an extensive educational background in medicine and research. She earned her Doctor of Medicine (M.D.) from Silesian Medical University, followed by a Doctor of Philosophy (Ph.D.) from the Children's Memorial Health Institute. She also completed a Postdoctoral Research Fellowship at the same institution. Additionally, she studied Business Administration and Management at Harvard Business School. Her expertise encompasses genetics, pediatrics, and various rare disease therapies, including enzyme replacement and gene therapy.
Professional Background
Agnieszka J. has held several significant roles in the pharmaceutical industry. Before joining BridgeBio, she worked as Senior Medical Director at Ultragenyx Pharmaceutical Inc. and Aegerion Pharmaceuticals. She also served as Medical Director at Shire Pharmaceuticals and as a Medical Consultant at BioMarin Pharmaceutical Inc. and Synageva BioPharma Corp. Her experience spans multiple regions, including Europe, Russia, and LATAM, providing her with a comprehensive understanding of global market dynamics.
Achievements in Clinical Development
Agnieszka J. has contributed to over 50 peer-reviewed publications focused on rare and ultra-rare diseases. She is recognized for her ability to communicate complex clinical information effectively, having presented at various advisory boards and congresses. Her work includes establishing partnerships with key opinion leaders, patient communities, and regulatory authorities, which enhances collaboration in the field of clinical development.
Skills and Interests
Agnieszka J. possesses strong interpersonal and personal development skills, particularly in leadership and team functionality. She is passionate about using the Enneagram as a tool for enhancing leadership excellence. Her ability to influence without authority and her planning skills are critical assets in her clinical development role. Agnieszka enjoys fostering relationships with centers of excellence and advocacy groups, further demonstrating her commitment to advancing healthcare solutions.